SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Mesoblast Ltd ADR (MESO)

MESO RSS Feed
Add MESO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/7/2017 8:28:57 AM - Followers: 6 - Board type: Free - Posts Today: 0

 

Mesoblast Limited ADR (NASDAQ: MESO)

 


NASDAQ-GS 
 

http://www.mesoblast.com


Non-U.S. Exchange Listing:  (MSB) ASX - Australian Securities Exchange

Quote with Bid and Offer (during ASX market hours)


Qualified Exchange

Mesoblast is listed on several world exchanges:

Symbol Company Name Prime Exchange
MSB.AX Mesoblast Limited Australia Stock Exchange
MESO.MU Mesoblast Limited Munich Stock Exchange
MESO.DE Mesoblast Limited Xetra
MESO.BE Mesoblast Limited Berlin Stock Exchange
MSBta.AX Mesoblast Limited Australia Stock Exchange
MESO.F Mesoblast Limited Frankfurt Stock Exchange

  

 

Company Information:

United States Operations

Australia Corporate Headquarters

Singapore

Mesoblast Inc.

505 Fifth Avenue
Level 3
New York, NY 10017

Mesoblast Limited

55 Collins Street
Level 38
Melbourne 3000

Mesoblast

20 Biopolis Way
#05-01 Centros
Biopreneur
Singapore 138668

TFN: 1 844 889 MESO
TFN: 1 844 889 6376
T: +1 212 880 2060
F: +1 212 880 2061
E: info@mesoblast.com

TFN: 1 800 89 MESO
TFN: 1 800 89 6376
T: +61 3 9639 6036
F: +61 3 9639 6030
E: info@mesoblast.com

TFN: 1 844 889 MESO
TFN: 1 800 889 6376
T: +65 6570 0635
F: +65 6570 0176
E: info@mesoblast.com

Mesoblast -  is a world leader in developing innovative cellular medicines.

We have established what we believe is the industry’s most clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2.

All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.

 

Management: http://www.mesoblast.com/company/management-team

 


Product Candidates Overview: http://www.mesoblast.com/product-candidates/product-candidates-overview
 

Investors & Media Home: http://investorsmedia.mesoblast.com/phoenix.zhtml?c=187006&p=irol-irhome

 

SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?company=mesoblast&owner=exclude&action=getcompany

 

Investor & Media Contact:

Michael Schuster
Global Head, Investor Relations

T: + 1 212 880 2060
E: michael.schuster@mesoblast.com

Julie Meldrum
Global Head, Corporate Communications

T: + 61 3 9639 6036
E: julie.meldrum@mesoblast.com

 

 

 

Non-U.S. Exchange Listing

(MSB) ASX - Australian Securities Exchange
Qualified Exchange

 

NASDAQ-GS   

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
MESO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MESO News: Report of Foreign Issuer (6-k) 09/19/2017 09:19:25 AM
MESO News: Report of Foreign Issuer (6-k) 09/07/2017 06:50:17 AM
MESO News: Report of Foreign Issuer (6-k) 09/01/2017 06:06:56 AM
MESO News: Annual and Transition Report (foreign Private Issuer) (20-f) 08/30/2017 07:25:46 AM
MESO News: Report of Foreign Issuer (6-k) 08/30/2017 06:06:12 AM
PostSubject
#160   stockguard 09/07/17 08:28:57 AM
#159   Mesoblast limited (MESO) Given a $14.00 Price Target stockguard 09/07/17 08:20:08 AM
#158   Analyst Actions: Oppenheimer Starts Mesoblast at Outperform, $16 stockguard 08/31/17 04:03:04 PM
#157   Mesoblast Limited looks a long way from take off stockguard 08/31/17 01:10:18 PM
#156   Why the Mesoblast limited share price plunged 10% stockguard 08/31/17 01:07:42 PM
#155   H11 halt Bernija1 08/25/17 09:20:30 AM
#154   Regenerating the Body With Stem Cells – Hype stockguard 07/12/17 12:33:03 PM
#153   Looks like Management is going to work the stockguard 07/10/17 12:18:34 PM
#152   Don`t even know if they have applied for stockguard 07/09/17 02:55:16 PM
#151   Question. With MESO receiving RMAT in March. Jimmy_Colechhi 07/09/17 10:57:22 AM
#150   Experimental stem-cell therapies getting the recognition to use stockguard 07/04/17 05:50:38 PM
#149   Good size blocks being picked up after news stockguard 06/22/17 02:56:43 PM
#148   Great interview with the CEO of MESO: AugustStockInformer 06/16/17 11:42:12 AM
#147   Nice 10,000 share block bought Friday morning way stockguard 05/14/17 10:34:39 AM
#146   TEVA ABANDONED their partnership w/ MESO TheHungryHippo 05/09/17 05:28:05 PM
#145   I notice, there hasn't been activity on this pennystocKING13 05/09/17 05:09:46 PM
#144   DO NOT BUY THIS GARBAGE STOCK. in my TheHungryHippo 05/04/17 06:39:08 PM
#143   COMPLETE POS STOCK! TheHungryHippo 05/04/17 06:38:33 PM
#141   Is ANYBODY out there...?!? seppi08162 04/15/17 12:48:01 PM
#140   ...Looks like noone's gotten back to you. Ive seppi08162 02/25/17 05:10:22 PM
#139   What is this worth? Noticed some drugs in P3 stoxx 09/26/16 09:32:09 PM
#138   Sending ticker via pm. KarinCA 02/04/14 04:43:03 PM
#137   Thanks. Who is their competitor? Stockbuilder 02/04/14 04:27:29 PM
#136   Without replying to a post there's no one KarinCA 02/04/14 03:39:53 PM
#135   POSITIVE SPINAL DISC REPAIR TRIAL RESULTS USING MESOBLAST SuperSquirrel 01/30/14 12:10:59 AM
#134   SuperSquirrel 01/30/14 12:10:40 AM
#133   Mesoblast Is No Match For Pluristem's IP And Manufacturing SuperSquirrel 01/28/14 09:31:50 PM
#132   Mesoblast Reports Positive Type 2 Diabetes Trial Results SuperSquirrel 12/03/13 11:30:15 PM
#131   New Japanese Regenerative Medicine Legislation and Commercial Opportunities SuperSquirrel 11/25/13 12:39:09 PM
#130   Mesoblast's Cell Therapy Strengthens Native Heart Function In SuperSquirrel 11/18/13 09:58:44 PM
#129   Continue to wait for an answer. Stockbuilder 10/24/13 08:34:47 AM
#128   Just discovered this interesting stock? Why is no Stockbuilder 09/19/13 09:42:25 AM
#127   $MBLTY - Mesoblast's Strong Cash Position Enables Execution KarinCA 09/04/13 01:25:45 AM
#126   Mesoblast Receives $4.3 Million from Australian Government for SuperSquirrel 07/18/13 07:53:12 PM
#125   MESOBLAST'S PRECLINICAL TRIAL RESULTS OF INTRACORONARY CELL THERAPY SuperSquirrel 05/14/13 11:28:03 PM
#124   The Vatican's Pontifical Council for Culture, NeoStem, The SuperSquirrel 04/11/13 12:34:25 AM
#123   The Stem Cell Revolution Can Jump Start Your SuperSquirrel 03/17/13 12:12:03 PM
#122   Mesoblast Completes A$170m Private Placement SuperSquirrel 03/17/13 12:10:46 PM
#121   MBLTY - FDA Agreement on Mesoblast's Use of KarinCA 02/13/13 01:17:38 PM
#120   It will be interesting to see how long KarinCA 12/05/11 02:26:17 AM
#119   It's quite interesting to see how this has KarinCA 10/08/11 01:10:48 PM
#118   MBLTY - Mesoblast Receives Clearance to Begin First KarinCA 09/05/11 09:16:37 PM
#117   Mesoblast Receives FDA Clearance for Phase 3 Bone KarinCA 07/07/11 11:51:39 AM
#116   KEY PATENTS GRANTED IN UNITED STATES STRENGTHEN KarinCA 06/02/11 01:33:18 PM
#115   Mesoblast deal inspires Teva to swoop on Cephalon SuperSquirrel 05/08/11 11:27:54 PM
#114   Teva: $500 Million Cost Savings From Cephalon Buy SuperSquirrel 05/04/11 09:06:34 PM
#113   Mesoblast Limited (ASX:MSB) Included In Standard And Poor/ASX SuperSquirrel 04/18/11 06:25:22 AM
#112   Mesoblast Limited (ASX:MSB) (PINK:MBLTY) wishes to inform the SuperSquirrel 04/08/11 03:46:34 PM
#111   I'll have to agree with you there... lol KarinCA 04/07/11 05:45:38 PM
#110   The CEPH deal with Mesoblast did not seem SuperSquirrel 03/29/11 10:28:42 PM
PostSubject